FDA Investigator: Maxwell L. Van Tassell
- Maxwell L. Van Tassell first started conducting FDA inspections in 2017, with the last inspection in 2019. Over that time, Maxwell L. Van Tassell has conducted 9 inspections at 9 companies across 9 sites.
Get Maxwell Van Tassell's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Astellas Pharma Tech, Toyama | October 2019
Available Now - $199
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Amgen Manufacturing, Juncos | May 2019
Available Now - $199
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Novartis Pharma AG, Basel | 2019
Out-of-stock
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, Andover | 2019
Out-of-stock
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Dompe Farmaceutici S.p.A., L'Aquila | 2018
Out-of-stock
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Hospira Zagreb d.o.o., Brdovec | 2018
Out-of-stock
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Chugai Pharmaceutical Co., Ltd., Kita | 2017
Out-of-stock
Maxwell L. Van Tassell
Human Drug Form 483
FDA 483 Rentschler Biotechnologie GmbH, Laupheim | 2017
Out-of-stock
Maxwell L. Van Tassell
Human Drug Form 483
Co-Investigators (9)
- Van Tassell, Maxwell L, FDA Investigator
- Wayne E. Seifert, FDA Investigator
- Reyes Candau-Chacon, FDA Investigator
- Marion Michaelis, FDA Investigator
- Bo Chi, FDA Investigator
- Maria J. Lopez- Barragan, FDA Investigator
- Ruth A. Moore, FDA Investigator
- Diane L. Raccasi, FDA Investigator
- Lopez- Barragan, Maria J, FDA Investigator